NCT03760276

A Study to Evaluate the Appropriateness of the Voriconazole Dosing Regimen

A Pilot Study to Evaluate the Appropriateness of the Voriconazole Dosing Regimen Based on the Population Pharmacokinetic Model and the Influence of Sex on the Pharmacokinetics of Voriconazole

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 11 (actual)
• Sponsor: Seoul National University Hospital · Academic / Other
• Sex: All
• Age: 20 Years – 45 Years
• Healthy volunteers: Accepted

Summary

A pilot study was performed to evaluate the appropriateness of the voriconazole dosing regimen based on the population pharmacokinetic model and the influence of sex on the pharmacokinetics of voriconazole

Conditions

• Fungal Infection

Interventions

Type	Name	Description
DRUG	Voriconazole Oral Product (Vfend®)	To be determined mg of Voriconazole (Vfend®, anti-fungal agent)

Timeline

• Start date: 2018-08-20
• Primary completion: 2018-10-28
• Completion: 2018-10-28
• First posted: 2018-11-30
• Last updated: 2018-11-30

Locations

1 site across 1 country: South Korea